查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1946644

2026年全球腫瘤醫療器材市場報告

Oncology Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤醫療器材市場發展迅速，預計將從2025年的1,777.2億美元成長到2026年的2,101.5億美元，複合年成長率達18.2%。過去幾年的成長可歸因於全球癌症發生率上升、醫院腫瘤科擴建、對早期診斷技術的需求不斷成長、先進診斷影像系統的廣泛應用以及人們對癌症篩檢計畫的意識提升等因素。

預計未來幾年腫瘤治療設備市場規模將快速成長，到2030年將達到3,972.7億美元，複合年成長率（CAGR）為17.3%。預測期內的成長將主要受以下因素驅動：個人化癌症治療設備的普及、腫瘤基礎設施投資的增加、門診癌症治療設施的擴張、人工智慧驅動的診斷工具的廣泛應用以及對精準腫瘤解決方案的日益重視。預測期內的關鍵趨勢包括：先進癌症診斷設備的普及、影像引導腫瘤治療的廣泛應用、微創癌症治療工具的日益整合、精準放射治療設備的擴展以及對早期癌症檢測的日益重視。

預計未來幾年，化療需求的成長將推動腫瘤醫療器材市場的擴張。化療是一種癌症治療方法，它使用強效藥物來清除快速分裂的癌細胞，從而減緩或阻止腫瘤的生長和擴散。全球癌症發生率的上升推動了化療需求的成長，而不斷增加的癌症診斷病例也促使人們需要針對各種癌症類型和階段提供有效且廣泛可用的治療方法。腫瘤醫療器材透過實現更安全、更精準的藥物輸送和監測來輔助化療，從而提高治療效果和患者預後。例如，根據美國聯邦癌症研究機構－國家癌症研究所（NCI）的數據，預計到2025年1月，美國新增癌症病例將達到204萬例，高於2023年的196萬例。這支撐了對化療輸送系統日益成長的需求。因此，化療需求的成長正在促進腫瘤醫療器材市場的成長。

腫瘤醫療器材市場的主要企業致力於開發先進的、精準的解決方案，旨在提高治療精度、病人安全性和臨床工作流程效率。這些創新技術專注於微創技術、改進的可視化和即時治療最佳化，從而支持多種癌症類型的成功治療。例如，2025年4月，總部位於德國的醫療科技公司蔡司（Zeiss）的INTRABEAM 700系統獲得了FDA 510(k)許可。 INTRABEAM 700系統是一款新一代機器人輔助術中放射治療（IORT）平台，用於神經腫瘤和乳癌手術中的標靶放射治療。該系統具有更高的精度、最佳化的符合人體工學的設計以及與手術流程的更佳整合，使臨床醫生能夠在手術過程中進行局部放射治療，同時減少周圍正常組織的輻射暴露。 INTRABEAM 700整合了先進的成像、機器人技術和治療計劃功能，提高了治療精度，加快了臨床決策速度，並支持了腫瘤治療行業向以患者為中心的技術先進型腫瘤治療模式的轉型。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球腫瘤醫療器材市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 先進癌症診斷設備的普及應用日益廣泛
    • 擴大影像導引癌症治療方法的應用
    • 微創癌症治療工具整合的進展
    • 精密放射治療設備的擴建
    • 人們越來越關注癌症早期檢測

第5章 終端用戶產業市場分析

  • 醫院
  • 癌症治療中心
  • 腫瘤診所
  • 癌症研究所
  • 診斷影像中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球腫瘤醫療器材市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球腫瘤醫療器材市場規模、對比及成長率分析
  • 全球腫瘤醫療器材市場表現：規模與成長，2020-2025年
  • 全球腫瘤醫療器材市場預測：規模與成長，2025-2030年，2035年

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依設備類型
  • 近距離放射治療裝置、內視鏡裝置
  • 透過治療
  • 化療、荷爾蒙療法、生物療法/免疫療法、放射線治療
  • 最終用戶
  • 醫院、癌症研究機構和其他最終用戶
  • 按類型細分：近距離放射治療設備
  • 後荷機（高劑量率 (HDR) 和低劑量率 (LDR)）、施藥器、種子和配件
  • 按類型細分：內視鏡設備
  • 內視鏡（軟式、硬式、膠囊式）、內視鏡超音波系統、內視鏡附件

第10章 區域與國家分析

  • 全球腫瘤醫療器材市場：區域表現及預測，2020-2025年、2025-2030年及2035年
  • 全球腫瘤醫療器材市場：國家、績效及預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 孟加拉國市場

第19章 泰國市場

第20章 越南市場

第21章 馬來西亞市場

第22章 新加坡市場

第23章：菲律賓市場

第24章 香港市場

第25章：紐西蘭市場

第26章 台灣市場

第27章 東南亞市場

第28章 西歐市場

第29章英國市場

第30章：德國市場

第31章：法國市場

第32章：義大利市場

第33章：西班牙市場

第34章：奧地利市場

第35章：比利時市場

第36章：丹麥市場

第37章 芬蘭市場

第38章：愛爾蘭市場

第39章：荷蘭市場

第40章：挪威市場

第41章：葡萄牙市場

第42章：瑞典市場

第42章 瑞士市場

第43章 東歐市場

第44章：俄羅斯市場

第45章：捷克市場

第46章：波蘭市場

第47章：羅馬尼亞市場

第48章：烏克蘭市場

第49章 北美市場

第50章：美國市場

第51章 加拿大市場

第52章：墨西哥市場

第53章 南美洲市場

第54章：巴西市場

第55章 智利市場

第56章：阿根廷市場

第57章：哥倫比亞市場

第58章 秘魯市場

第59章 中東市場

第60章：沙烏地阿拉伯市場

第61章：以色列市場

第62章 伊朗市場

第63章 土耳其市場

第64章：阿拉伯聯合大公國市場

第65章：非洲市場

第66章 埃及市場

第67章：奈及利亞市場

第68章 南非市場

第69章 市場監理與投資環境

第70章：競爭格局與公司概況

  • 腫瘤醫療器材市場：競爭格局及市場佔有率（2024年）
  • 腫瘤醫療器材市場：公司估值矩陣
  • 腫瘤醫療器材市場：公司概況
    • Eckert & Ziegler BEBIG GmbH
    • Oncura Inc.
    • GE Healthcare
    • Medtronic plc
    • Varian Medical Systems Inc.

第71章：其他領先和創新企業

  • Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer

第72章：全球市場競爭基準分析與儀錶板

第73章：重大併購

第74章：高潛力市場國家、細分市場與策略

  • 2030年腫瘤醫療器材市場：蘊藏新機會的國家
  • 2030年腫瘤醫療器材市場：新興細分市場機會
  • 2030年腫瘤醫療器材市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第75章附錄

簡介目錄
Product Code: ME2MODEV04_G26Q1

Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.

The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.

Tariffs are influencing the oncology devices market by increasing costs of imported imaging systems, radiation therapy equipment, endoscopic devices, precision components, and electronic subsystems used in cancer diagnosis and treatment. Hospitals and cancer centers in North America and Europe are most affected due to reliance on imported high-end oncology equipment, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital investment requirements and slowing technology upgrades. However, they are also encouraging domestic manufacturing, localized assembly of oncology systems, and innovation in cost-efficient cancer care technologies.

The oncology devices market research report is one of a series of new reports from The Business Research Company that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology devices market size has grown rapidly in recent years. It will grow from $177.72 billion in 2025 to $210.15 billion in 2026 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to increasing global cancer incidence rates, expansion of hospital oncology departments, growing demand for early diagnosis technologies, availability of advanced imaging systems, rising awareness of cancer screening programs.

The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $397.27 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment devices, rising investments in oncology infrastructure, expansion of outpatient cancer treatment facilities, growing use of AI-driven diagnostic tools, increasing focus on precision oncology solutions. Major trends in the forecast period include increasing adoption of advanced cancer diagnostic devices, rising use of image-guided oncology therapies, growing integration of minimally invasive cancer treatment tools, expansion of precision radiation therapy equipment, enhanced focus on early cancer detection.

The growing demand for chemotherapy is anticipated to drive the expansion of the oncology devices market in the coming years. Chemotherapy is a cancer treatment that involves the use of potent drugs to eliminate rapidly dividing cells, thereby slowing or halting tumor growth and spread. The rising demand for chemotherapy is driven by the increasing global incidence of cancer, as a higher number of diagnosed cases leads to greater need for effective and widely available treatments capable of addressing various cancer types and stages. Oncology devices support chemotherapy by facilitating safer and more accurate drug delivery and monitoring, which improves treatment efficacy and patient outcomes. For example, in January 2025, according to the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, new cancer cases in the United States are projected to reach 2.04 million, up from 1.96 million in 2023, underscoring the growing need for chemotherapy administration systems. Therefore, the rising demand for chemotherapy is contributing to the growth of the oncology devices market.

Major companies operating in the oncology devices market are concentrating on the development of advanced, precision-oriented solutions to enhance treatment accuracy, patient safety, and clinical workflow efficiency. These innovations focus on minimally invasive technologies, improved visualization, and real-time therapy optimization to support better outcomes across a wide range of cancer types. For example, in April 2025, ZEISS, a Germany-based medical technology company, obtained FDA 510(k) clearance for its INTRABEAM 700 system, a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform intended for targeted radiation delivery in neuro-oncology and breast cancer procedures. The system provides increased precision, optimized ergonomics, and improved integration into surgical workflows, allowing clinicians to deliver localized radiation during surgery while reducing exposure to surrounding healthy tissue. By integrating advanced imaging, robotics, and treatment-planning capabilities, the INTRABEAM 700 improves therapeutic accuracy, enables faster clinical decision-making, and supports the industry's transition toward technologically sophisticated, patient-focused oncology care.

In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.

Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Brachytherapy Devices; Endoscopic Devices
  • 2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radition Therapy
  • 3) By End User: Hospitals; Cancer Research Institutes; Other End Users
  • Subsegments:
  • 1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)); Applicators; Seeds; Accessories
  • 2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule); Endoscopic Ultrasound Systems; Endoscopic Accessories
  • Companies Mentioned: Eckert & Ziegler BEBIG GmbH; Oncura Inc.; GE Healthcare; Medtronic plc; Varian Medical Systems Inc.; Elekta AB; Theragenics Corporation; Accuray Incorporated; Roche Diagnostics; IBA Group; Biogenex Laboratories; Becton Dickinson and Company; Siemens Healthineers; Philips Healthcare; Hologic Inc.; IBA AG; ViewRay Inc.; Canon Medical Systems Corporation; Brainlab; PerkinElmer; RaySearch Laboratories; Mevion Medical Systems; Vision RT; IsoRay; RefleXion Medical; Alpha Tau Medical; Nanobiotix; Mirada Medical Ltd.; Navidea Biopharmaceuticals Inc.
  • Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Oncology Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Oncology Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Oncology Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Oncology Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Advanced Cancer Diagnostic Devices
    • 4.2.2 Rising Use Of Image-Guided Oncology Therapies
    • 4.2.3 Growing Integration Of Minimally Invasive Cancer Treatment Tools
    • 4.2.4 Expansion Of Precision Radiation Therapy Equipment
    • 4.2.5 Enhanced Focus On Early Cancer Detection

5. Oncology Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Oncology Clinics
  • 5.4 Cancer Research Institutes
  • 5.5 Diagnostic Imaging Centers

6. Oncology Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Oncology Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Oncology Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Oncology Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Devices Market Segmentation

  • 9.1. Global Oncology Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Brachytherapy Devices, Endoscopic Devices
  • 9.2. Global Oncology Devices Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy
  • 9.3. Global Oncology Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cancer Research Institutes, Other End Users
  • 9.4. Global Oncology Devices Market, Sub-Segmentation Of Brachytherapy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories
  • 9.5. Global Oncology Devices Market, Sub-Segmentation Of Endoscopic Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories

10. Oncology Devices Market Regional And Country Analysis

  • 10.1. Global Oncology Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Oncology Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Devices Market

  • 11.1. Asia-Pacific Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Devices Market

  • 12.1. China Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Devices Market

  • 13.1. India Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Devices Market

  • 14.1. Japan Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Devices Market

  • 15.1. Australia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Devices Market

  • 16.1. Indonesia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Devices Market

  • 17.1. South Korea Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh Oncology Devices Market

  • 18.1. Bangladesh Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand Oncology Devices Market

  • 19.1. Thailand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam Oncology Devices Market

  • 20.1. Vietnam Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia Oncology Devices Market

  • 21.1. Malaysia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore Oncology Devices Market

  • 22.1. Singapore Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines Oncology Devices Market

  • 23.1. Philippines Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong Oncology Devices Market

  • 24.1. Hong Kong Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand Oncology Devices Market

  • 25.1. New Zealand Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan Oncology Devices Market

  • 26.1. Taiwan Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Taiwan Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia Oncology Devices Market

  • 27.1. South East Asia Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. South East Asia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe Oncology Devices Market

  • 28.1. Western Europe Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. Western Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK Oncology Devices Market

  • 29.1. UK Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany Oncology Devices Market

  • 30.1. Germany Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France Oncology Devices Market

  • 31.1. France Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy Oncology Devices Market

  • 32.1. Italy Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain Oncology Devices Market

  • 33.1. Spain Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria Oncology Devices Market

  • 34.1. Austria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium Oncology Devices Market

  • 35.1. Belgium Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark Oncology Devices Market

  • 36.1. Denmark Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland Oncology Devices Market

  • 37.1. Finland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland Oncology Devices Market

  • 38.1. Ireland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands Oncology Devices Market

  • 39.1. Netherlands Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway Oncology Devices Market

  • 40.1. Norway Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal Oncology Devices Market

  • 41.1. Portugal Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden Oncology Devices Market

  • 42.1. Sweden Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland Oncology Devices Market

  • 42.1. Switzerland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe Oncology Devices Market

  • 43.1. Eastern Europe Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 43.2. Eastern Europe Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia Oncology Devices Market

  • 44.1. Russia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic Oncology Devices Market

  • 45.1. Czech Republic Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland Oncology Devices Market

  • 46.1. Poland Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania Oncology Devices Market

  • 47.1. Romania Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine Oncology Devices Market

  • 48.1. Ukraine Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America Oncology Devices Market

  • 49.1. North America Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 49.2. North America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA Oncology Devices Market

  • 50.1. USA Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 50.2. USA Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada Oncology Devices Market

  • 51.1. Canada Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 51.2. Canada Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico Oncology Devices Market

  • 52.1. Mexico Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 52.2. Mexico Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America Oncology Devices Market

  • 53.1. South America Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 53.2. South America Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil Oncology Devices Market

  • 54.1. Brazil Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile Oncology Devices Market

  • 55.1. Chile Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina Oncology Devices Market

  • 56.1. Argentina Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia Oncology Devices Market

  • 57.1. Colombia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru Oncology Devices Market

  • 58.1. Peru Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East Oncology Devices Market

  • 59.1. Middle East Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 59.2. Middle East Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia Oncology Devices Market

  • 60.1. Saudi Arabia Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel Oncology Devices Market

  • 61.1. Israel Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran Oncology Devices Market

  • 62.1. Iran Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey Oncology Devices Market

  • 63.1. Turkey Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates Oncology Devices Market

  • 64.1. United Arab Emirates Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa Oncology Devices Market

  • 65.1. Africa Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 65.2. Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt Oncology Devices Market

  • 66.1. Egypt Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria Oncology Devices Market

  • 67.1. Nigeria Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa Oncology Devices Market

  • 68.1. South Africa Oncology Devices Market, Segmentation By Device Type, Segmentation By Therapy, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. Oncology Devices Market Regulatory and Investment Landscape

70. Oncology Devices Market Competitive Landscape And Company Profiles

  • 70.1. Oncology Devices Market Competitive Landscape And Market Share 2024
    • 70.1.1. Top 10 Companies (Ranked by revenue/share)
  • 70.2. Oncology Devices Market - Company Scoring Matrix
    • 70.2.1. Market Revenues
    • 70.2.2. Product Innovation Score
    • 70.2.3. Brand Recognition
  • 70.3. Oncology Devices Market Company Profiles
    • 70.3.1. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.2. Oncura Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

71. Oncology Devices Market Other Major And Innovative Companies

  • Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer

72. Global Oncology Devices Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The Oncology Devices Market

74. Oncology Devices Market High Potential Countries, Segments and Strategies

  • 74.1 Oncology Devices Market In 2030 - Countries Offering Most New Opportunities
  • 74.2 Oncology Devices Market In 2030 - Segments Offering Most New Opportunities
  • 74.3 Oncology Devices Market In 2030 - Growth Strategies
    • 74.3.1 Market Trend Based Strategies
    • 74.3.2 Competitor Strategies

75. Appendix

  • 75.1. Abbreviations
  • 75.2. Currencies
  • 75.3. Historic And Forecast Inflation Rates
  • 75.4. Research Inquiries
  • 75.5. The Business Research Company
  • 75.6. Copyright And Disclaimer